Tech Company Financing Transactions
PineTree Therapeutics Funding Round
PineTree Therapeutics closed a $17 million Series A funding round on 7/30/2024. Investors included DSC Investment, STIC Investments and Atinum Investment.
Transaction Overview
Company Name
Announced On
7/30/2024
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series A
Investors
DSC Investment (Lead Investor)
STIC Investments (Lead Investor)
Proceeds Purpose
The company intends to use the funds to leverage its AbReptor� antibody degrader platform to advance its novel multispecific TPD development programs across multiple tumor types and targets in several oncology indications, with potential application in other therapeutic areas.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
c/o Ipsen Innovation Center 650 East Kendall Street
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
PineTree Therapeutics Inc. is a preclinical stage Biotechnology company that is pioneering the development of disruptive therapies in Oncology and Infectious Diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Clemens Reinshagen
Chief Executive Officer
Hojuhn Song
Chief Financial Officer
Bennett Goldstein
Browse more venture capital transactions:
Prev: 7/30/2024: Stairpay venture capital transaction
Next: 7/30/2024: Monto venture capital transaction
Share this article
News on VC Transactions
We record tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs